Clozapine Normalizes a Glutamatergic Transmission Abnormality Induced by an Impaired NMDA Receptor in the Thalamocortical Pathway via the Activation of a Group III Metabotropic Glutamate Receptor
Pharmacological mechanisms of gold-standard antipsychotics against treatment-refractory schizophrenia, such as clozapine (CLZ), remain unclear. We aimed to explore the mechanisms of CLZ by investigating the effects of MK801 and CLZ on tripartite synaptic transmission in the thalamocortical glutamate...
Main Authors: | Kouji Fukuyama, Ryo Kato, Masahiko Murata, Takashi Shiroyama, Motohiro Okada |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-06-01
|
Series: | Biomolecules |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-273X/9/6/234 |
Similar Items
-
Cystine/Glutamate Antiporter and Aripiprazole Compensate NMDA Antagonist-Induced Dysfunction of Thalamocortical L-Glutamatergic Transmission
by: Kouji Fukuyama, et al.
Published: (2018-11-01) -
Role of Metabotropic Glutamate Receptors in Neurological Disorders
by: Rosalia Crupi, et al.
Published: (2019-02-01) -
Differential expression of metabotropic glutamate and GABAB receptors at neocortical glutamatergic and GABAergic axon terminals
by: Luca eBragina, et al.
Published: (2015-09-01) -
Glutamate receptors and glutamatergic signalling in the peripheral nerves
by: Ting-Jiun Chen, et al.
Published: (2020-01-01) -
Glutamatergic Mechanisms in Glioblastoma and Tumor-Associated Epilepsy
by: Falko Lange, et al.
Published: (2021-05-01)